Jagsonpal Pharmaceuticals Limited — Others, 28-04-2025: Spurt in Volume

Jagsonpal Pharmaceuticals has addressed the stock exchange's inquiry regarding a notable surge in trading volume of its securities. The company confirmed that all material information has been appropriately disclosed to comply with listing regulations, and no additional disclosures are necessary at this time.

This clarification may help mitigate investor concerns over unusual trading activity, providing a more stable outlook for the stock. Investors may view this as a sign of transparency, reducing perceived risks associated with the sudden increase in trading volume.